Jianglong Xu

机构：CCTEG Shenyang Research Institute, Shenzhen Children's Hospital

发表论文 21 篇 · 总被引 421 次 · h-index 9

代表论文

• m6A modification in RNA: biogenesis, functions and roles in gliomas (2020 · Journal of Experimental & Clinical Cancer Research · 被引 165)
• Exosomal circWDR62 promotes temozolomide resistance and malignant progression through regulation of the miR-370-3p/MGMT axis in glioma (2022 · Cell Death and Disease · 被引 58)
• Identification of new QTL for salt tolerance from rice variety Pokkali (2020 · Journal of Agronomy and Crop Science · 被引 40)
• lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy (2022 · Frontiers in Oncology · 被引 33)
• Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition (2024 · Cancer Biology and Medicine · 被引 31)
• EPIC-0307-mediated selective disruption of PRADX–EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT (2023 · Neuro-Oncology · 被引 19)